Filana Therapeutics (FLNA) Operating Expenses (2010 - 2026)
Filana Therapeutics (FLNA) posted quarterly Operating Expenses of $9.4 million for Q2 2026, down 79.31% year-over-year from $45.4 million in Q2 2025, and down 15.89% quarter-over-quarter from $11.2 million in Q1 2026.
Filana Therapeutics (FLNA) Operating Expenses (2010 - 2026) Analysis & Trends
Filana Therapeutics' Operating Expenses history runs 17 years deep, the most recent figure standing at $9.4 million for Q2 2026.
- In Q2 2026, Operating Expenses fell 79.31% year-over-year to $9.4 million; the TTM figure through Jun 2026 stood at $46.0 million (down 64.66% YoY), while the FY2025 annual figure was $95.4 million, down 32.56% from the prior year.
- Operating Expenses for Q2 2026 stood at $9.4 million, down from $11.2 million in the prior quarter.
- The five-year high for Operating Expenses was $61.4 million in Q2 2024, with the low at $9.4 million in Q2 2026.
- The 5-year median for Operating Expenses is $22.1 million (2022), against an average of $24.6 million.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses jumped 404.42% in 2022, then tumbled 79.31% in 2026.
- Filana Therapeutics' Operating Expenses stood at $20.9 million in 2022, then rose by 8.85% to $22.8 million in 2023, then grew by 29.39% to $29.5 million in 2024, then sank by 54.04% to $13.6 million in 2025, then slumped by 30.69% to $9.4 million in 2026.
- Business Quant data shows FLNA's Operating Expenses at $9.4 million in Q2 2026, $11.2 million in Q1 2026, and $13.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Filana Therapeutics | 45.29 Mn | 45.29 Mn | - | 9.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.39 Mn |
| Mar 31, 2026 | 11.17 Mn |
| Dec 31, 2025 | 13.55 Mn |
| Sep 30, 2025 | 11.86 Mn |
| Jun 30, 2025 | 45.39 Mn |
| Mar 31, 2025 | 24.59 Mn |
| Dec 31, 2024 | 29.49 Mn |
| Sep 30, 2024 | 30.62 Mn |
| Jun 30, 2024 | 61.40 Mn |
| Mar 31, 2024 | 19.93 Mn |
| Dec 31, 2023 | 22.79 Mn |
| Sep 30, 2023 | 27.88 Mn |
| Jun 30, 2023 | 28.78 Mn |
| Mar 31, 2023 | 26.51 Mn |
| Dec 31, 2022 | 20.94 Mn |
| Sep 30, 2022 | 21.35 Mn |
| Jun 30, 2022 | 19.92 Mn |
| Mar 31, 2022 | 17.82 Mn |
| Dec 31, 2021 | 14.44 Mn |
| Sep 30, 2021 | 9.75 Mn |